Uterine fibroids, a condition affecting up to 80% of women, often lead to symptoms like severe pain, anemia, and fertility issues, significantly impacting quality of life. Historically, fibroids have been a primary reason for hysterectomies, but new recommendations from Mayo Clinic researchers in The New England Journal of Medicine suggest prioritizing minimally invasive alternatives. Dr. Shannon Laughlin-Tommaso, Mayo Clinic OB-GYN and co-lead author, emphasizes that less invasive treatments enable quicker recovery and offer health benefits by preserving the uterus and ovaries, which may reduce the risk of cardiovascular disease, depression, anxiety, and higher mortality rates associated with hysterectomy—especially in younger women. Research indicates that nearly 60% of women undergoing hysterectomy for fibroids hadn’t first explored alternative treatments, such as hormone-releasing IUDs, radiofrequency ablation, focused ultrasound, and uterine artery embolization.
These options allow women to maintain their uteruses longer, potentially preserving fertility and lessening emotional distress, which many women report, including depression and body image concerns. Early detection is essential, as fibroids are often easier to treat when smaller, but routine screenings typically occur only after symptoms become severe. The prevalence of fibroids rises with age and is notably higher among Black women, who often experience more severe cases. Dr. Ebbie Stewart, co-lead author, advocates for improved screening, especially among younger Black women and those with a family history, to address health disparities and prevent long-term complications. While hysterectomy remains a common solution due to its ease and universal availability, the Mayo Clinic team suggests that understanding and utilizing alternative treatments can better meet patients’ diverse needs, potentially improving their overall health and well-being.
Read More
